Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lundbeck

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lundbeck's 2013 CNS (central nervous system) sales performance.

Lundbeck trial failure dashes hopes in Alzheimer's once again

Lundbeck trial failure dashes hopes in Alzheimer's once again A phase III trial of Lundbeck's 5-HT6 inhibitor idalopirdine has failed to meet its objectives in the first of three pivotal trials in Alzheimer's disease, despite promising phase ... Lundbeck said it was disappointed by the outcome, but was waiting for

Lundbeck challenge to EC pay-for-delay ruling fails

Lundbeck challenge to EC pay-for-delay ruling fails Lundbeck was unable justify why the agreements were needed to protect its intellectual property rights on Celexa, according to the Commission. ... Lundbeck insists it did not go beyond the protection already offered by its patent rights on Celexa.

Newron back on track for Xadago approval in US

Newron back on track for Xadago approval in US The monoamine oxidase type B inhibitor is used as an add-on to levodopa therapy - the mainstay of Parkinson's disease treatment - and competes with Lundbeck and Teva's Azilect (rasagiline),

Surging sales of Lundbeck's CNS drugs assist recovery

Surging sales of Lundbeck's CNS drugs assist recovery Two newer antidepressants help boost sales after Cipralex patent ends.  . Surging sales of four new central nervous system drugs helped Denmark's Lundbeck post a 5% sales increase in the second ... Lundbeck has now raised its revenue and earnings

SMC gives green light for BMS’ Opdivo

SMC gives green light for BMS’ Opdivo 2014. Additionally, the SMC gave three further approvals to Lundbeck's antidepressant Brintellix (vortioxetine), Novartis' Cosentyx (secukinumab) for ankylosing spondylitis, and UCB's Briviact (brivaracetam) for partial-onset seizures in epilepsy

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics